American Regent

American Regent, Inc. is a prominent U.S.-based pharmaceutical company founded in 1967. It specializes in the development, manufacturing, and delivery of high-quality sterile injectable products for both human and animal health. As a member of the Daiichi Sankyo Group, American Regent has established itself as a leader in the pharmaceutical industry, with sales nearing one billion dollars. The company offers a diverse range of products, including branded and generic injectables, and has a strong presence in IV iron therapy. Its animal health division has been providing solutions for over 40 years, focusing on the well-being of horses and dogs. American Regent's product portfolio encompasses various pharmaceutical forms and therapeutic areas, including injectables, ophthalmics, and biologics, addressing a wide array of health needs. American Regent is dedicated to improving health outcomes by providing innovative and accessible products. The company emphasizes quality and reliability, investing in modernizing its manufacturing facilities to meet market demands. Its key branded products include Injectafer® for IV iron therapy and animal health brands like Adequan® and BetaVet®. The company serves a broad customer base, ensuring essential medicines are available for both human patients and animals.